- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01535053
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES:
I. To test the hypothesis that treatment with multi-day methotrexate is inferior to treatment with pulse actinomycin-D (dactinomycin) in patients with low-risk gestational trophoblastic disease with respect to complete response.
SECONDARY OBJECTIVES:
I. To describe the frequency of post protocol surgical treatment for each arm. II. To describe the frequency of post protocol multi-agent chemotherapy treatment for each arm.
III. To compare multi-day methotrexate to actinomycin-D with respect to frequency and severity of adverse events in patients with low-risk gestational trophoblastic neoplasia.
IV. To investigate the impact of treatment on overall quality-of-life (QOL) and explore the influence of treatment on issues such as body image, sexual functioning, and patient-reported side effects and disruption.
V. To assess whether uterine artery pulsatility index (UAPI) can provide independent prognostic information predictive of single-drug resistance.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM I: Patients receive dactinomycin intravenously (IV) over 15 minutes on day 1.
ARM II: Patients receive methotrexate intramuscularly (IM) on days 1, 3, 5, and 7 and leucovorin calcium orally (PO) on days 2, 4, 6, and 8 OR single agent methotrexate IV on days 1-5.
In both arms, treatment repeats every 14 days for up to 20 courses* in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up monthly for 1 year and then every 3 months for 1 year.
NOTE: * Patients will be treated for three courses after human chorionic gonadotropin (hCG) < 5 mIU/mL or until evidence of treatment failure (biologic progression), disease progression, or unacceptable toxicity despite dose modifications. Upon normalization of hCG (< 5 mIU/mL), patients will be treated with three additional courses.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M4N 3M5
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
-
-
Quebec
-
Montreal, Quebec, Canada, H2L 4M1
- CHUM - Hopital Notre-Dame
-
-
-
-
-
Hiroshima City, Japan, 734-8551
- Hiroshima University Hospital
-
Osaka, Japan, 589 8511
- Kindai University
-
Saitama, Japan, 350-1298
- Saitama Medical University International Medical Center
-
Tottori, Japan, 680-8550
- Tottori University
-
-
Aoba-ku
-
Sendai, Aoba-ku, Japan, 980-8574
- Tohoku University School of Medicine
-
-
Hiroshima
-
Kure, Hiroshima, Japan, 737
- Kure National Hospital
-
-
Hokkaido
-
Sapporo, Hokkaido, Japan, 060-8648
- Hokkaido University Hospital
-
-
Iwate
-
Shiwa-gun, Iwate, Japan, 028-3695
- Iwate Medical University Hospital
-
-
Kagoshima
-
Kagoshima City, Kagoshima, Japan, 890-8760
- Kagoshima City Hospital
-
-
Niigata
-
Niigata City, Niigata, Japan, 951-8520
- Niigata University Medical And Dental Hospital
-
-
Okinawa
-
Nakagami-gun, Okinawa, Japan, 903-0215
- University of the Ryukyus Hospital-Col Health Scnc
-
-
-
-
-
Incheon, Korea, Republic of, 405-760
- Gachon University Gil Hospital
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
Seoul, Korea, Republic of, 05505
- Asan Medical Center
-
Seoul, Korea, Republic of, 06273
- Gangnam Severance Hospital
-
Seoul, Korea, Republic of, 139-706
- Korea Cancer Center Hospital
-
-
Korea
-
Seoul, Korea, Korea, Republic of, 135-710
- Samsung Medical Center
-
Seoul, Korea, Korea, Republic of, 137-040
- Catholic University of Korea-Seoul Saint Mary's Hospital
-
-
Kyeonggi-do
-
Seongnam City, Kyeonggi-do, Korea, Republic of, 463-707
- Seoul National University Bundang Hospital
-
-
-
-
England
-
Sheffield, England, United Kingdom, S10 2SJ
- Weston Park Hospital
-
-
-
-
Alaska
-
Anchorage, Alaska, United States, 98508
- Anchorage Associates in Radiation Medicine
-
Anchorage, Alaska, United States, 99508
- Alaska Breast Care and Surgery LLC
-
Anchorage, Alaska, United States, 99508
- Alaska Oncology and Hematology LLC
-
Anchorage, Alaska, United States, 99508
- Alaska Women's Cancer Care
-
Anchorage, Alaska, United States, 99508
- Anchorage Oncology Centre
-
Anchorage, Alaska, United States, 99508
- Katmai Oncology Group
-
Anchorage, Alaska, United States, 99508
- Providence Alaska Medical Center
-
Anchorage, Alaska, United States, 99504
- Anchorage Radiation Therapy Center
-
Anchorage, Alaska, United States, 99508
- Alaska Regional Hospital
-
-
Arizona
-
Phoenix, Arizona, United States, 85004
- Cancer Center at Saint Joseph's
-
Phoenix, Arizona, United States, 85013
- Saint Joseph's Hospital and Medical Center
-
-
California
-
Burbank, California, United States, 91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
La Jolla, California, United States, 92093
- UC San Diego Moores Cancer Center
-
Loma Linda, California, United States, 92354
- Loma Linda University Medical Center
-
Los Angeles, California, United States, 90027
- Kaiser Permanente Los Angeles Medical Center
-
-
Connecticut
-
Hartford, Connecticut, United States, 06102
- Hartford Hospital
-
New Britain, Connecticut, United States, 06050
- The Hospital of Central Connecticut
-
-
Georgia
-
Atlanta, Georgia, United States, 30342
- Northside Hospital
-
Augusta, Georgia, United States, 30912
- Augusta University Medical Center
-
Cumming, Georgia, United States, 30041
- Northside Hospital-Forsyth
-
Decatur, Georgia, United States, 30033
- Dekalb Medical Center
-
Gainesville, Georgia, United States, 30501
- Northeast Georgia Medical Center-Gainesville
-
Savannah, Georgia, United States, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
Savannah, Georgia, United States, 31404
- Memorial Health University Medical Center
-
Savannah, Georgia, United States, 31404
- Summit Cancer Care-Memorial
-
Savannah, Georgia, United States, 31404
- Low Country Cancer Care
-
-
Idaho
-
Boise, Idaho, United States, 83712
- Saint Luke's Cancer Institute - Boise
-
Coeur d'Alene, Idaho, United States, 83814
- Kootenai Health - Coeur d'Alene
-
Fruitland, Idaho, United States, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, United States, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, United States, 83686
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, United States, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, United States, 83864
- Kootenai Cancer Clinic
-
Twin Falls, Idaho, United States, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Aurora, Illinois, United States, 60504
- Rush - Copley Medical Center
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
Chicago, Illinois, United States, 60637
- University of Chicago Comprehensive Cancer Center
-
Danville, Illinois, United States, 61832
- Carle on Vermilion
-
Effingham, Illinois, United States, 62401
- Carle Physician Group-Effingham
-
Evanston, Illinois, United States, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Glenview, Illinois, United States, 60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Highland Park, Illinois, United States, 60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Hinsdale, Illinois, United States, 60521
- Sudarshan K Sharma MD Limited-Gynecologic Oncology
-
Mattoon, Illinois, United States, 61938
- Carle Physician Group-Mattoon/Charleston
-
Mount Vernon, Illinois, United States, 62864
- Good Samaritan Regional Health Center
-
New Lenox, Illinois, United States, 60451
- UC Comprehensive Cancer Center at Silver Cross
-
Skokie, Illinois, United States, 60076
- North Shore Medical Center
-
Urbana, Illinois, United States, 61801
- Carle Cancer Center
-
Urbana, Illinois, United States, 61801
- The Carle Foundation Hospital
-
Yorkville, Illinois, United States, 60560
- Rush-Copley Healthcare Center
-
-
Indiana
-
Elkhart, Indiana, United States, 46515
- Elkhart General Hospital
-
Elkhart, Indiana, United States, 46514
- Michiana Hematology Oncology PC-Elkhart
-
Elkhart, Indiana, United States, 46514-2098
- Elkhart Clinic
-
Indianapolis, Indiana, United States, 46260
- Saint Vincent Hospital and Health Care Center
-
Kokomo, Indiana, United States, 46904
- Community Howard Regional Health
-
La Porte, Indiana, United States, 46350
- IU Health La Porte Hospital
-
Michigan City, Indiana, United States, 46360
- Franciscan Saint Anthony Health-Michigan City
-
Michigan City, Indiana, United States, 46360
- Woodland Cancer Care Center
-
Mishawaka, Indiana, United States, 46545
- Memorial Regional Cancer Center Day Road
-
Mishawaka, Indiana, United States, 46545
- Michiana Hematology Oncology PC-Mishawaka
-
Mishawaka, Indiana, United States, 46545
- Cancer Care Partners LLC
-
Mishawaka, Indiana, United States, 46545
- Saint Joseph Regional Medical Center-Mishawaka
-
Plymouth, Indiana, United States, 46563
- Michiana Hematology Oncology PC-Plymouth
-
South Bend, Indiana, United States, 46601
- Memorial Hospital of South Bend
-
South Bend, Indiana, United States, 46601
- Michiana Hematology Oncology PC-South Bend
-
South Bend, Indiana, United States, 46628
- Northern Indiana Cancer Research Consortium
-
South Bend, Indiana, United States, 46617
- South Bend Clinic
-
Westville, Indiana, United States, 46391
- Michiana Hematology Oncology PC-Westville
-
-
Iowa
-
Sioux City, Iowa, United States, 51101
- Siouxland Regional Cancer Center
-
Sioux City, Iowa, United States, 51102
- Mercy Medical Center-Sioux City
-
Sioux City, Iowa, United States, 51104
- Saint Luke's Regional Medical Center
-
-
Kentucky
-
Edgewood, Kentucky, United States, 41017
- Saint Elizabeth Healthcare Edgewood
-
-
Maine
-
Portland, Maine, United States, 04102
- Maine Medical Center-Bramhall Campus
-
Scarborough, Maine, United States, 04074
- Maine Medical Center- Scarborough Campus
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland/Greenebaum Cancer Center
-
Bethesda, Maryland, United States, 20889-5600
- Walter Reed National Military Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
-
Michigan
-
Battle Creek, Michigan, United States, 49017
- Bronson Battle Creek
-
Grand Rapids, Michigan, United States, 49503
- Spectrum Health at Butterworth Campus
-
Grand Rapids, Michigan, United States, 49503
- Mercy Health Saint Mary's
-
Grand Rapids, Michigan, United States, 49503
- Cancer Research Consortium of West Michigan NCORP
-
Kalamazoo, Michigan, United States, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, United States, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, United States, 49048
- Borgess Medical Center
-
Monroe, Michigan, United States, 48162
- Monroe Cancer Center
-
Muskegon, Michigan, United States, 49444
- Mercy Health Mercy Campus
-
Niles, Michigan, United States, 49120
- Lakeland Hospital Niles
-
Reed City, Michigan, United States, 49677
- Spectrum Health Reed City Hospital
-
Saint Joseph, Michigan, United States, 49085
- Lakeland Medical Center Saint Joseph
-
Saint Joseph, Michigan, United States, 49085
- Marie Yeager Cancer Center
-
Traverse City, Michigan, United States, 49684
- Munson Medical Center
-
Wyoming, Michigan, United States, 49519
- Metro Health Hospital
-
-
Minnesota
-
Burnsville, Minnesota, United States, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, United States, 55433
- Mercy Hospital
-
Edina, Minnesota, United States, 55435
- Fairview Southdale Hospital
-
Fridley, Minnesota, United States, 55432
- Unity Hospital
-
Hutchinson, Minnesota, United States, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, United States, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, United States, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, United States, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, United States, 55454
- Health Partners Inc
-
New Ulm, Minnesota, United States, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, United States, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, United States, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, United States, 55416
- Metro Minnesota Community Oncology Research Consortium
-
Saint Paul, Minnesota, United States, 55101
- Regions Hospital
-
Saint Paul, Minnesota, United States, 55102
- United Hospital
-
Shakopee, Minnesota, United States, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, United States, 55082
- Lakeview Hospital
-
Waconia, Minnesota, United States, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, United States, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, United States, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
-
Missouri
-
Bolivar, Missouri, United States, 65613
- Central Care Cancer Center - Bolivar
-
Branson, Missouri, United States, 65616
- Cox Cancer Center Branson
-
Joplin, Missouri, United States, 64804
- Freeman Health System
-
Joplin, Missouri, United States, 64804
- Mercy Hospital Joplin
-
Rolla, Missouri, United States, 65401
- Delbert Day Cancer Institute at PCRMC
-
Rolla, Missouri, United States, 65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
Saint Louis, Missouri, United States, 63110
- Barnes-Jewish Hospital
-
Saint Louis, Missouri, United States, 63141
- Mercy Hospital Saint Louis
-
Saint Louis, Missouri, United States, 63109
- Saint Louis Cancer and Breast Institute-South City
-
Springfield, Missouri, United States, 65804
- Cancer Research for the Ozarks NCORP
-
Springfield, Missouri, United States, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, United States, 65804
- Mercy Hospital Springfield
-
-
Montana
-
Anaconda, Montana, United States, 59711
- Community Hospital of Anaconda
-
Billings, Montana, United States, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, United States, 59101
- Saint Vincent Healthcare
-
Billings, Montana, United States, 59102
- Montana Cancer Consortium NCORP
-
Bozeman, Montana, United States, 59715
- Bozeman Deaconess Hospital
-
Butte, Montana, United States, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, United States, 59405
- Great Falls Clinic
-
Great Falls, Montana, United States, 59405
- Benefis Healthcare- Sletten Cancer Institute
-
Helena, Montana, United States, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, United States, 59901
- Kalispell Regional Medical Center
-
Missoula, Montana, United States, 59804
- Community Medical Hospital
-
Missoula, Montana, United States, 59802
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, United States, 59802
- Montana Cancer Specialists
-
-
Nevada
-
Las Vegas, Nevada, United States, 89106
- Women's Cancer Center of Nevada
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87102
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, United States, 87106
- Southwest Gynecologic Oncology Associates Inc
-
-
New York
-
Brooklyn, New York, United States, 11203
- State University of New York Downstate Medical Center
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28203
- Carolinas Medical Center/Levine Cancer Institute
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Ohio
-
Akron, Ohio, United States, 44304
- Summa Health System - Akron Campus
-
Belpre, Ohio, United States, 45714
- Strecker Cancer Center-Belpre
-
Chillicothe, Ohio, United States, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, United States, 45220
- Good Samaritan Hospital - Cincinnati
-
Cincinnati, Ohio, United States, 45242
- Bethesda North Hospital
-
Cleveland, Ohio, United States, 44106
- Case Western Reserve University
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, United States, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, United States, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, United States, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, United States, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, United States, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, United States, 43228
- Doctors Hospital
-
Columbus, Ohio, United States, 43215
- Grant Medical Center
-
Columbus, Ohio, United States, 43222
- Mount Carmel Health Center West
-
Columbus, Ohio, United States, 43215
- Columbus NCI Community Oncology Research Program
-
Delaware, Ohio, United States, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, United States, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, United States, 43015
- Grady Memorial Hospital
-
Lancaster, Ohio, United States, 43130
- Fairfield Medical Center
-
Lancaster, Ohio, United States, 43130
- Lancaster Radiation Oncology
-
Marietta, Ohio, United States, 45750
- Marietta Memorial Hospital
-
Mayfield Heights, Ohio, United States, 44124
- Hillcrest Hospital Cancer Center
-
Mentor, Ohio, United States, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Mount Vernon, Ohio, United States, 43050
- Knox Community Hospital
-
Newark, Ohio, United States, 43055
- Licking Memorial Hospital
-
Newark, Ohio, United States, 43055
- Newark Radiation Oncology
-
Portsmouth, Ohio, United States, 45662
- Southern Ohio Medical Center
-
Springfield, Ohio, United States, 45505
- Springfield Regional Medical Center
-
Sylvania, Ohio, United States, 43560
- ProMedica Flower Hospital
-
Westerville, Ohio, United States, 43081
- Saint Ann's Hospital
-
Zanesville, Ohio, United States, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, United States, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Oregon
-
Bend, Oregon, United States, 97701
- Saint Charles Health System
-
Clackamas, Oregon, United States, 97015
- Clackamas Radiation Oncology Center
-
Clackamas, Oregon, United States, 97015
- Providence Cancer Institute Clackamas Clinic
-
Coos Bay, Oregon, United States, 97420
- Bay Area Hospital
-
Newberg, Oregon, United States, 97132
- Providence Newberg Medical Center
-
Oregon City, Oregon, United States, 97045
- Providence Willamette Falls Medical Center
-
Portland, Oregon, United States, 97213
- Providence Portland Medical Center
-
Portland, Oregon, United States, 97225
- Providence Saint Vincent Medical Center
-
-
Pennsylvania
-
Abington, Pennsylvania, United States, 19001
- Jefferson Abington Hospital
-
Beaver, Pennsylvania, United States, 15009
- UPMC-Heritage Valley Health System Beaver
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
Greensburg, Pennsylvania, United States, 15601
- UPMC Cancer Centers - Arnold Palmer Pavilion
-
Hazleton, Pennsylvania, United States, 18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Johnstown, Pennsylvania, United States, 15901
- UPMC-Johnstown/John P. Murtha Regional Cancer Center
-
McKeesport, Pennsylvania, United States, 15132
- UPMC Cancer Center at UPMC McKeesport
-
Moon, Pennsylvania, United States, 15108
- UPMC-Coraopolis/Heritage Valley Radiation Oncology
-
Philadelphia, Pennsylvania, United States, 19140
- Temple University Hospital
-
Pittsburgh, Pennsylvania, United States, 15213
- UPMC-Magee Womens Hospital
-
Pittsburgh, Pennsylvania, United States, 15232
- University of Pittsburgh Cancer Institute (UPCI)
-
Pittsburgh, Pennsylvania, United States, 15232
- UPMC-Shadyside Hospital
-
Pittsburgh, Pennsylvania, United States, 15213
- UPMC-Presbyterian Hospital
-
Pittsburgh, Pennsylvania, United States, 15215
- UPMC-Saint Margaret
-
Pittsburgh, Pennsylvania, United States, 15236
- UPMC Jefferson Regional Radiation Oncology
-
Pittsburgh, Pennsylvania, United States, 15237
- UPMC-Passavant Hospital
-
Pittsburgh, Pennsylvania, United States, 15243
- UPMC-Saint Clair Hospital Cancer Center
-
Seneca, Pennsylvania, United States, 16346
- UPMC Cancer Center at UPMC Northwest
-
State College, Pennsylvania, United States, 16801
- Geisinger Medical Group
-
Uniontown, Pennsylvania, United States, 15401
- UPMC Uniontown Hospital Radiation Oncology
-
Washington, Pennsylvania, United States, 15301
- UPMC Washington Hospital Radiation Oncology
-
West Reading, Pennsylvania, United States, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, United States, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02905
- Women and Infants Hospital
-
-
South Carolina
-
Greenville, South Carolina, United States, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, United States, 29601
- Saint Francis Hospital
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37920
- University of Tennessee - Knoxville
-
-
Texas
-
Austin, Texas, United States, 78701
- Dell Seton Medical Center at The University of Texas
-
Dallas, Texas, United States, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, United States, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
-
Washington
-
Aberdeen, Washington, United States, 98520
- Providence Regional Cancer System-Aberdeen
-
Anacortes, Washington, United States, 98221
- Cancer Care Center at Island Hospital
-
Bellevue, Washington, United States, 98005
- Swedish Cancer Institute-Eastside Oncology Hematology
-
Bellingham, Washington, United States, 98225
- PeaceHealth Saint Joseph Medical Center
-
Centralia, Washington, United States, 98531
- Providence Regional Cancer System-Centralia
-
Edmonds, Washington, United States, 98026
- Swedish Cancer Institute-Edmonds
-
Everett, Washington, United States, 98201
- Providence Regional Cancer Partnership
-
Issaquah, Washington, United States, 98029
- Swedish Cancer Institute-Issaquah
-
Lacey, Washington, United States, 98503
- Providence Regional Cancer System-Lacey
-
Longview, Washington, United States, 98632
- PeaceHealth Saint John Medical Center
-
Seattle, Washington, United States, 98107
- Swedish Medical Center-Ballard Campus
-
Seattle, Washington, United States, 98112
- Kaiser Permanente Washington
-
Seattle, Washington, United States, 98104
- Minor and James Medical PLLC
-
Seattle, Washington, United States, 98104
- Pacific Gynecology Specialists
-
Seattle, Washington, United States, 98122-4307
- Swedish Medical Center-First Hill
-
Shelton, Washington, United States, 98584
- Providence Regional Cancer System-Shelton
-
Spokane, Washington, United States, 99204
- MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
-
Spokane, Washington, United States, 99218
- MultiCare Deaconess Cancer and Blood Specialty Center - North
-
Spokane Valley, Washington, United States, 99216
- MultiCare Deaconess Cancer and Blood Specialty Center - Valley
-
Vancouver, Washington, United States, 98664
- PeaceHealth Southwest Medical Center
-
Walla Walla, Washington, United States, 99362
- Providence Saint Mary Regional Cancer Center
-
Yakima, Washington, United States, 98902
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
Yelm, Washington, United States, 98597
- Providence Regional Cancer System-Yelm
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26505
- Monongalia Hospital
-
-
Wisconsin
-
Burlington, Wisconsin, United States, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Fond Du Lac, Wisconsin, United States, 54937
- Aurora Health Center-Fond du Lac
-
Germantown, Wisconsin, United States, 53022
- Aurora Health Care Germantown Health Center
-
Grafton, Wisconsin, United States, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, United States, 54311
- Aurora BayCare Medical Center
-
Kenosha, Wisconsin, United States, 53142
- Aurora Cancer Care-Kenosha South
-
Marinette, Wisconsin, United States, 54143
- Aurora Bay Area Medical Group-Marinette
-
Marinette, Wisconsin, United States, 54143
- Bay Area Medical Center
-
Milwaukee, Wisconsin, United States, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, United States, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, United States, 53233
- Aurora Sinai Medical Center
-
New Richmond, Wisconsin, United States, 54017
- Cancer Center of Western Wisconsin
-
Oshkosh, Wisconsin, United States, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Racine, Wisconsin, United States, 53406
- Aurora Cancer Care-Racine
-
Sheboygan, Wisconsin, United States, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Summit, Wisconsin, United States, 53066
- Aurora Medical Center in Summit
-
Two Rivers, Wisconsin, United States, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Waukesha, Wisconsin, United States, 53188
- Aurora Cancer Care-Waukesha
-
Wauwatosa, Wisconsin, United States, 53226
- Aurora Cancer Care-Milwaukee West
-
West Allis, Wisconsin, United States, 53227
- Aurora West Allis Medical Center
-
-
Wyoming
-
Casper, Wyoming, United States, 82609
- Rocky Mountain Oncology
-
Cody, Wyoming, United States, 82414
- Big Horn Basin Cancer Center
-
Cody, Wyoming, United States, 82414
- Billings Clinic-Cody
-
Sheridan, Wyoming, United States, 82801
- Welch Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients who meet International Federation of Gynecology and Obstetrics (FIGO) stage I, II, or III criteria for low-risk gestational trophoblastic neoplasia (GTN): post molar GTN or choriocarcinoma (as defined below); patients may have had a second curettage but must still meet GTN criteria below:
Post molar GTN
For the purposes of this study, patients must have undergone evacuation of a complete or partial hydatidiform mole and then meet the criteria for GTN defined as:
- A < 10% decrease in the hCG level using as a reference the first value in the series of 4 values taken over a period of 3 weeks (> 50 mIU/ml minimum) OR
- A > 20% sustained rise in the hCG taking as a reference the first value in the series of 3 values taken over a period of 2 weeks (> 50 mIU/ml minimum) OR
- A persistently elevated hCG level a period of 6 months or more following the initial curettage (> 50 mIU/ml minimum)
Choriocarcinoma
- Histologically proven non-metastatic choriocarcinoma OR
- Histologically proven metastatic choriocarcinoma if the metastatic site(s) is restricted to one (or more) of the following: vagina, parametrium, or lung
- World Health Organization (WHO) risk score 0-6
- Patients must be willing to practice effective contraception for the duration of the study
- White blood cell count (WBC) >= 3,000 cells/mcL
- Granulocytes >= 1,500/mcL
- Platelets >= 100,000/mcL
- Creatinine =< 2.0 mg/dcL
- Bilirubin =< 1.5 x institutional normal
- Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< 3 x institutional normal
- Alkaline phosphatase =< 3 x institutional normal
- Patients who have met the pre-entry requirements
- Before enrolling a patient, the institution must verify the availability of an adequate supply of methotrexate for a full course of therapy
- Patients must have signed an approved informed consent and authorization permitting release of personal health information
Exclusion Criteria:
- Patients who do not have GTN
- Patients with non-gestational choriocarcinoma
- Patients who have previously been treated with cytotoxic chemotherapy; however, patients who received prior low-dose methotrexate for treatment of an ectopic pregnancy will be eligible for this study
- Patients who have received prior pelvic radiation
- Patients with placental-site trophoblastic tumor (PSTT) or epithelioid trophoblastic tumor (ETT)
- Patients with Gynecologic Oncology Group (GOG) performance status of 3 or 4
- Patients with a history of other invasive malignancies, with the exception of non-melanoma skin cancer, are excluded if there is any evidence of other malignancy being present within the last five years; patients are also excluded if their previous cancer treatment contraindicates this protocol therapy
- Patients whose circumstances at the time of study entry do not permit completion of the study or required follow-up
- Patients who wish to breast-feed during treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm I (dactinomcin)
Patients receive dactinomycin IV over 15 minutes on day 1.
|
Ancillary studies
Other Names:
Given IV
Other Names:
|
|
Active Comparator: Arm II (leucovorin calcium and methotrexate)
Patients receive methotrexate IM on days 1, 3, 5, and 7 and leucovorin calcium PO on days 2, 4, 6, and 8 OR single agent methotrexate IV on days 1-5.
|
Ancillary studies
Other Names:
Given PO
Other Names:
Given IV and IM
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Participants With Complete Response
Time Frame: hCG testing is performed prior to each cycle to treatment until treatment is completed, up to 10 months. For patients who have responded to treatment hCG must be obtained every 4 weeks for 1 year after completing treatment.
|
Complete Response is defined as 3 consecutive bi-weekly values of hCG<5 over a minimum of 4 weeks of normal hCG values with no values greater than 5 mIU/ml
|
hCG testing is performed prior to each cycle to treatment until treatment is completed, up to 10 months. For patients who have responded to treatment hCG must be obtained every 4 weeks for 1 year after completing treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With CTCAE v4 Graded Adverse Events With Low-risk Gestational Trophoblastic Neoplasia by Arm
Time Frame: Assessed throughout the treatment period and within 2-4 weeks after discontinuation of treatment
|
Maximum grade of physician assessed adverse events reported during treatment
|
Assessed throughout the treatment period and within 2-4 weeks after discontinuation of treatment
|
|
The Number of Participants With Post Protocol Surgical Treatment for Each Arm.
Time Frame: Anytime during post treatment follow-up for up to 2 years from study entry.
|
Anytime during post treatment follow-up for up to 2 years from study entry.
|
|
|
The Number of Participants With Post Protocol Multi-agent Chemotherapy Treatment for Each Arm.
Time Frame: Anytime during post treatment follow-up for up to 2 years from study entry.
|
Anytime during post treatment follow-up for up to 2 years from study entry.
|
|
|
Patient-reported Quality of Life (QOL) at Baseline
Time Frame: Prior to cycle 1
|
Patient reported quality of life was measured with the Functional Assessment of Cancer Therapy - Generic (FACT-G).
The FACT-G is a scale for assessing general QOL of cancer patients.
It consists of four subscales: Physical Well Being, Functional Well Being, Social/Family Well-Being, and Emotional Well-Being.
Each item in the FACT-G was scored using a 5-point scale (0=not at all; 1=a little bit; 2=somewhat; 3=quite a bit; 4=very much).
For the negative statements, reversal was performed prior to score calculation.
According to the FACIT measurement system, a subscale score was the summation of the individual item scores if more than 50% of subscale items were answered.
When unanswered items existed, a subscale score was prorated by multiplying the mean of the answered item scores by the number of items in the subscale.
The FACT-G score is calculated as the sum of the subscale scores.
The FACT-G score ranges 0-108.
A larger score suggests better QOL.
|
Prior to cycle 1
|
|
Patient-reported Quality of Life (QOL) After Baseline Visit.
Time Frame: Prior to cycle 3 (4 weeks after cycle 1 if off study treatment prior to cycle 3). Prior to cycle 5, Prior to cycle 7, 26 weeks after starting study treatment.
|
Patient reported quality of life was measured with the Functional Assessment of Cancer Therapy - Generic (FACT-G).
The FACT-G is a scale for assessing general QOL of cancer patients.
It consists of four subscales: Physical Well Being, Functional Well Being, Social/Family Well-Being, and Emotional Well-Being.
Each item in the FACT-G was scored using a 5-point scale (0=not at all; 1=a little bit; 2=somewhat; 3=quite a bit; 4=very much).
For the negative statements, reversal was performed prior to score calculation.
According to the FACIT measurement system, a subscale score was the summation of the individual item scores if more than 50% of subscale items were answered.
When unanswered items existed, a subscale score was prorated by multiplying the mean of the answered item scores by the number of items in the subscale.
The FACT-G score is calculated as the sum of the subscale scores.
The FACT-G score ranges 0-108.
A larger score suggests better QOL.
|
Prior to cycle 3 (4 weeks after cycle 1 if off study treatment prior to cycle 3). Prior to cycle 5, Prior to cycle 7, 26 weeks after starting study treatment.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Julian C Schink, NRG Oncology
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms by Histologic Type
- Neoplasms
- Adenocarcinoma
- Carcinoma
- Neoplasms, Glandular and Epithelial
- Neoplasms, Germ Cell and Embryonal
- Pregnancy Complications
- Pregnancy Complications, Neoplastic
- Trophoblastic Neoplasms
- Gestational Trophoblastic Disease
- Hydatidiform Mole
- Choriocarcinoma
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Nucleic Acid Synthesis Inhibitors
- Enzyme Inhibitors
- Antirheumatic Agents
- Antimetabolites, Antineoplastic
- Antimetabolites
- Antineoplastic Agents
- Immunosuppressive Agents
- Immunologic Factors
- Protective Agents
- Dermatologic Agents
- Micronutrients
- Anti-Bacterial Agents
- Protein Synthesis Inhibitors
- Antibiotics, Antineoplastic
- Vitamins
- Bone Density Conservation Agents
- Calcium-Regulating Hormones and Agents
- Reproductive Control Agents
- Antidotes
- Vitamin B Complex
- Hematinics
- Abortifacient Agents, Nonsteroidal
- Abortifacient Agents
- Folic Acid Antagonists
- Leucovorin
- Calcium
- Levoleucovorin
- Methotrexate
- Folic Acid
- Calcium, Dietary
- Dactinomycin
Other Study ID Numbers
- GOG-0275 (Other Identifier: CTEP)
- U10CA180868 (U.S. NIH Grant/Contract)
- U10CA027469 (U.S. NIH Grant/Contract)
- NCI-2012-00250 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- CDR0000725211
- PGOG-0275_A08PAMDREVW01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hydatidiform Mole
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedNon-Metastatic Gestational Trophoblastic Tumor | Complete Hydatidiform Mole | Partial Hydatidiform MoleUnited States, Canada
-
Hospices Civils de LyonRecruitingHydatidiform Mole | Gestational Trophoblastic Disease | Neoplasm, Trophoblastic | Hydatidiform Mole, InvasiveFrance
-
Baylor College of MedicineActive, not recruitingHydatidiform MolesUnited States
-
King's College Hospital NHS TrustUniversity College, LondonActive, not recruitingAbortion, Spontaneous | Missed Abortion | Miscarriage in First Trimester | Incomplete Miscarriage | Hydatidiform Mole (Diagnosis)United Kingdom
-
Obstetrics & Gynecology Hospital of Fudan UniversityShandong University; Peking Union Medical College Hospital; Shengjing Hospital; The Affiliated Hospital of Qingdao University and other collaboratorsRecruitingHydatidiform MoleChina
-
Women's Hospital School Of Medicine Zhejiang UniversityNot yet recruitingHydatidiform Mole
-
University of the PhilippinesCompleted
-
Nilratan Sircar Medical CollegeUnknownHydatidiform MoleIndia
-
Brigham and Women's HospitalUniversidade Federal do Rio de Janeiro; Maternidade Escola da Universidade... and other collaboratorsRecruitingGestational Trophoblastic Neoplasia | Molar Pregnancy | Gestational Trophoblastic Tumor, Non-MetastaticBrazil
-
Women's Hospital School Of Medicine Zhejiang UniversityQilu Hospital of Shandong University; First Affiliated Hospital of Wenzhou... and other collaboratorsRecruitingHydatidiform Mole | Gestational Trophoblastic NeoplasiaChina
Clinical Trials on Quality-of-Life Assessment
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Germ Cell Tumor | Ovarian Sarcoma | Malignant Ovarian Epithelial Tumor | Ovarian Carcinosarcoma | Ovarian Brenner Tumor | Ovarian Mucinous... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Malignant NeoplasmUnited States
-
Wake Forest University Health SciencesWithdrawnLung Metastases | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
Kantonsspital AarauRecruiting
-
Jonsson Comprehensive Cancer CenterWithdrawnInfiltrating Bladder Urothelial CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedBreast CarcinomaUnited States
-
Case Comprehensive Cancer CenterActive, not recruitingUnspecified Adult Solid Tumor | Tumors Metastatic to BrainUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States